Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapy.
Breekveldt ECH, Ykema BLM, Bisseling TM, Moons LMG, Spaander MCW, Huibregtse IL, van der Biessen-van Beek DTJ, Mulder SF, Saveur L, Kerst JM, Zweers D, Suelmann BBM, de Wit R, Reijm A, van Baalen S, Butterly LF, Hisey WM, Robinson CM, van Vuuren AJ, Carvalho B, Lansdorp-Vogelaar I, Schaapveld M, van Leeuwen FE, Snaebjornsson P, van Leerdam ME. Breekveldt ECH, et al. Among authors: van vuuren aj, van leerdam me, van der biessen van beek dtj, van leeuwen fe, van baalen s. Int J Cancer. 2024 Apr 15;154(8):1474-1483. doi: 10.1002/ijc.34810. Epub 2023 Dec 27. Int J Cancer. 2024. PMID: 38151749
Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer.
Mulder SA, van Leerdam ME, van Vuuren AJ, Francke J, van Toorenenbergen AW, Kuipers EJ, Ouwendijk RJ. Mulder SA, et al. Among authors: van toorenenbergen aw, van vuuren aj, van leerdam me. Eur J Gastroenterol Hepatol. 2007 Oct;19(10):878-82. doi: 10.1097/MEG.0b013e3282cfa49c. Eur J Gastroenterol Hepatol. 2007. PMID: 17873612
Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.
Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME. Hol L, et al. Among authors: van der valk h, van der togt ac, van vuuren aj, van leerdam me, van ballegooijen m. Br J Cancer. 2009 Apr 7;100(7):1103-10. doi: 10.1038/sj.bjc.6604961. Br J Cancer. 2009. PMID: 19337257 Free PMC article. Clinical Trial.
Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ. Hol L, et al. Among authors: van dekken h, van der togt ac, van vuuren aj, van leerdam me, van ballegooijen m. Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089. Gut. 2010. PMID: 19671542 Clinical Trial.
Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
Hol L, de Jonge V, van Leerdam ME, van Ballegooijen M, Looman CW, van Vuuren AJ, Reijerink JC, Habbema JD, Essink-Bot ML, Kuipers EJ. Hol L, et al. Among authors: van vuuren aj, van leerdam me, van ballegooijen m. Eur J Cancer. 2010 Jul;46(11):2059-66. doi: 10.1016/j.ejca.2010.03.022. Epub 2010 Jun 4. Eur J Cancer. 2010. PMID: 20621736 Clinical Trial.
Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance.
van Roon AH, Wilschut JA, Hol L, van Ballegooijen M, Reijerink JC, 't Mannetje H, Kranenburg LJ, Biermann K, van Vuuren AJ, Francke J, van der Togt AC, Habbema DJ, van Leerdam ME, Kuipers EJ. van Roon AH, et al. Among authors: van der togt ac, van vuuren aj, van leerdam me, van ballegooijen m. Clin Gastroenterol Hepatol. 2011 Apr;9(4):333-9. doi: 10.1016/j.cgh.2010.12.012. Epub 2010 Dec 23. Clin Gastroenterol Hepatol. 2011. PMID: 21185397
276 results